MVASI (bevacizumab) Injection, 100 mg/4 mL Single-Dose Vial
MVASI is a biosimilar to Avastin (bevacizumab), supplied as a sterile, preservative-free solution for intravenous infusion. Each single-dose vial contains 100 mg of bevacizumab in 4 mL (25 mg/mL). It is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-small cell lung cancer, and others.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
MVASI is a biosimilar to Avastin (bevacizumab), supplied as a sterile, preservative-free solution for intravenous infusion. Each single-dose vial contains 100 mg of bevacizumab in 4 mL (25 mg/mL). It is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-small cell lung cancer, and others.
1 vendor
